These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 7833218)

  • 21. Adrenergic mechanisms in canine hindlimb circulation.
    Brungardt JM; Swan KG; Reynolds DG
    Cardiovasc Res; 1974 May; 8(3):423-9. PubMed ID: 4153267
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparative actions of selected vasoactive drugs on isolated human uterine arteries.
    Dyer DC; Gough ED
    Am J Obstet Gynecol; 1971 Nov; 111(6):820-5. PubMed ID: 5166391
    [No Abstract]   [Full Text] [Related]  

  • 23. [The resistive and capacity functions of the subcutaneous vein under blockade of calcium channels and endothelial factors].
    Kudriashov IuA; Tsviashchenko TIu
    Ross Fiziol Zh Im I M Sechenova; 2011 Jan; 97(1):57-64. PubMed ID: 21516750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of ischaemia on endothelium-dependent vasodilatation and adrenoceptor-mediated vasoconstriction in rat isolated hearts.
    Pannangpetch P; Woodman OL
    Br J Pharmacol; 1996 Mar; 117(6):1047-52. PubMed ID: 8882595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Activation of "silent" vasoconstrictive 5-HT1A receptors as a possible mechanism of synergism in angiotensin II and serotonin effect on vascular tone].
    Kozhevnikova LM; Sukhanova IF; Avdonin PV
    Izv Akad Nauk Ser Biol; 2011; (1):68-76. PubMed ID: 21446059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical pharmacology, physiology and pathophysiology of superficial veins--1.
    Aellig WH
    Br J Clin Pharmacol; 1994 Sep; 38(3):181-96. PubMed ID: 7826819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calcitonin gene-related peptide inhibits angiotensin II-mediated vasoconstriction in human radial arteries: role of the Kir channel.
    Zulli A; Ye B; Wookey PJ; Buxton BF; Hare DL
    J Thorac Cardiovasc Surg; 2008 Aug; 136(2):370-5. PubMed ID: 18692643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A vascular contractility bioassay using bovine right ruminal artery and vein.
    Klotz JL; Bush LP; Strickland JR
    J Anim Sci; 2011 Jun; 89(6):1944-51. PubMed ID: 21297058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vasoconstriction is determined by interstitial rather than circulating angiotensin II.
    Schuijt MP; de Vries R; Saxena PR; Schalekamp MA; Danser AH
    Br J Pharmacol; 2002 Jan; 135(1):275-83. PubMed ID: 11786504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigation of blood flow and the effect of vasoactive substances in cutaneous blood vessels of Xenopus laevis.
    Škorjanc A; Belušič G
    Adv Physiol Educ; 2015 Jun; 39(2):91-5. PubMed ID: 26031724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on the venoconstrictor effect of ergot compounds in man.
    Aellig WH
    Triangle; 1975; 14(1):39-46. PubMed ID: 1162728
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of heating on the hemodynamic responses to vasoactive agents.
    Massett MP; Lewis SJ; Kregel KC
    Am J Physiol; 1998 Sep; 275(3):R844-53. PubMed ID: 9728083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparative characteristics of constrictor effects of physiologically active substances on the internal carotid artery].
    Mchedlishvili GI; Ormotsadze LG
    Patol Fiziol Eksp Ter; 1978; (2):36-40. PubMed ID: 673476
    [No Abstract]   [Full Text] [Related]  

  • 34. Insulin modulation of an endothelial nitric oxide component present in the alpha2- and beta-adrenergic responses in human forearm.
    Lembo G; Iaccarino G; Vecchione C; Barbato E; Izzo R; Fontana D; Trimarco B
    J Clin Invest; 1997 Oct; 100(8):2007-14. PubMed ID: 9329964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cardiovascular drugs and diabetes].
    Larcan A; Royer R; Lambert H
    Diabete; 1971; 19(3):149-61. PubMed ID: 4400314
    [No Abstract]   [Full Text] [Related]  

  • 36. Drug-exercise interactions.
    Lowenthal DT; Kendrick ZV
    Annu Rev Pharmacol Toxicol; 1985; 25():275-305. PubMed ID: 2860845
    [No Abstract]   [Full Text] [Related]  

  • 37. Vasopressors and low-flow states.
    Hershey SG; Altura BM
    Clin Anesth; 1974; 10(1):31-76. PubMed ID: 4149702
    [No Abstract]   [Full Text] [Related]  

  • 38. beta(1) Receptors protect the renal afferent arteriole of angiotensin-infused rabbits from norepinephrine-induced oxidative stress.
    Wang D; Jose P; Wilcox CS
    J Am Soc Nephrol; 2006 Dec; 17(12):3347-54. PubMed ID: 17108317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reactivity of the vessels of collapsed and ventilated lungs to drugs and hypoxia.
    Barer GR
    Circ Res; 1966 Apr; 18(4):366-78. PubMed ID: 4157322
    [No Abstract]   [Full Text] [Related]  

  • 40. Exogenous NO administration and alpha-adrenergic vasoconstriction in human limbs.
    Rosenmeier JB; Fritzlar SJ; Dinenno FA; Joyner MJ
    J Appl Physiol (1985); 2003 Dec; 95(6):2370-4. PubMed ID: 12923119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.